MYO News and Press, Myomo Inc. From 06/08/21

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its applicati...

RALEIGH, NC / ACCESSWIRE / May 27, 2021 / The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Summer Solstice - Best Ideas fro...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that CEO Paul R. Gudonis and CFO...

Myomo has a revolutionary product that allows people with paralyzed arms to use them once more. Triple-digit growth will be fuelled by a number of catalysts both in the US as well as internationally. Key KPIs hit record levels in Q1 as Myomo ramped up advertising after the electio...

Myomo, Inc. (MYO) Q1 2021 Earnings Conference Call May 05, 2021 16:30 P.M. ET Company Participants Kim Golodetz - Lippert/Heilshorn & Associates David A. Henry - CFO Paul R. Gudonis - Chairman, President, & CEO Conference Call Participants Scott Henry - ROTH Capital Partners Kayla Hos...

Myomo (MYO): Q1 GAAP EPS of -$0.57.Revenue of $2.34M (+131.7% Y/Y)Press Release For further details see: Myomo reports Q1 results

Revenue of $2.3 million up 132% over prior year Gross margin of 73% up 500 basis points over prior year Q1 cash used in operations decreased 14% to $2.1 million Conference call begins at 4:30 p.m. Eastern time today Myomo, Inc. (NYSE American: MYO) (&#x...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial re...

Thomas Jefferson University Successfully Controls MyoPro Directly from Brain Implant Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering f...

Myomo develops, manufactures, and sells a wearable medical device for stroke patients that lost control or strength in their arms. Myomo's recent quarter and future growth prospects look bright in part because they received the Medicare Certification. They are overhauling their ma...